Scientists spotted RPS-12 protein as a potential target for anti-cancer therapy
Using the developing eye of the fruit fly as a test platform, researchers found that RPS-12 protein overproduction appears to trigger triple-negative breast cancer and possibly some other malignancies. The protein indirectly switches on an important inracellular signaling pathway active while the embryo develops and shut down in healthy cells of adults. Far Eastern Federal University (FEFU), the University of Geneva, and the Institute of Protein Research (Russia) scientists addressed the problem in Scientific Reports.
Researchers have taken another step towards targeted treatment of tumors. The idea of such a therapy is to identify the necessary ...














